UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 80.00
0.00 (0.00%)
At close: Mar 24, 2026
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 5.09 billion as of March 24, 2026. Its market cap has increased by 23.10% in one year.
Market Cap
5.09B
Enterprise Value
4.41B
Revenue
30.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
80.00
Market Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 5.09B, an increase of 194.63%. That is a compound annual growth rate of 22.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 5.09B | -6.36% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 5.92B |
| Sinphar Pharmaceutical | 5.90B |
| Steminent Biotherapeutics | 5.79B |
| Panion & Bf Biotech | 5.32B |
| Senhwa Biosciences | 5.10B |
| Pharmosa Biopharm | 5.05B |
| Locus Cell | 5.01B |
| OBI Pharma | 5.01B |